Solar radius and luminosity variations induced by the internal dynamo magnetic fields

Although the occurrence of solar irradiance variations induced by magnetic surface features (e.g., sunspots, faculae, magnetic network) is generally accepted, the existence of intrinsic luminosity changes due to the internal magnetic fields is still controversial. This additional contribution is expected to be accompanied by radius variations, and to be potentially significant for the climate of the Earth. We aim to constrain theoretically the radius and luminosity variations of the Sun that are due to the effect of the variable magnetic fields in its interior associated with the dynamo cycle. We have extended a one-dimensional stellar evolution code to include several effects of the magnetic fields on the interior structure. We investigate different magnetic configurations, based on both observational constraints and on the output of state-of-the-art mean field dynamo models. We explore both step-like and simply periodic time dependences of the magnetic field peak strength. We find that the luminosity and radius variations are in anti-phase and in phase, respectively, with the magnetic field strength. For peak magnetic field strengths of the order of tens of kilogauss, luminosity variations ranging between 10^{-6} and 10^{-3} (in modulus) and radius variations between 10^{-6} and 10^{-5} are obtained. Modest but significant radius variations (up to 10^{-5} in relative terms) are obtained for magnetic fields of realistic strength and geometry, providing a potentially observable signature of the intrinsic variations. Establishing their existence in addition to the accepted surface effects would have very important implications for the understanding of solar-induced long-term trends on climate.Comment: 18 pages, 7 figures; accepted for publication in Astronomische Nachrichte

Angular momentum transport efficiency in post-main sequence low-mass stars

Context. Using asteroseismic techniques, it has recently become possible to probe the internal rotation profile of low-mass (~1.1-1.5 Msun) subgiant and red giant stars. Under the assumption of local angular momentum conservation, the core contraction and envelope expansion occurring at the end of the main sequence would result in a much larger internal differential rotation than observed. This suggests that angular momentum redistribution must be taking place in the interior of these stars. Aims. We investigate the physical nature of the angular momentum redistribution mechanisms operating in stellar interiors by constraining the efficiency of post-main sequence rotational coupling. Methods. We model the rotational evolution of a 1.25 Msun star using the Yale Rotational stellar Evolution Code. Our models take into account the magnetic wind braking occurring at the surface of the star and the angular momentum transport in the interior, with an efficiency dependent on the degree of internal differential rotation. Results. We find that models including a dependence of the angular momentum transport efficiency on the radial rotational shear reproduce very well the observations. The best fit of the data is obtained with an angular momentum transport coefficient scaling with the ratio of the rotation rate of the radiative interior over that of the convective envelope of the star as a power law of exponent ~3. This scaling is consistent with the predictions of recent numerical simulations of the Azimuthal Magneto-Rotational Instability. Conclusions. We show that an angular momentum transport process whose efficiency varies during the stellar evolution through a dependence on the level of internal differential rotation is required to explain the observed post-main sequence rotational evolution of low-mass stars.Comment: 8 pages, 6 figures; accepted for publication in Astronomy & Astrophysic

Creep, Relaxation and Viscosity Properties for Basic Fractional Models in Rheology

The purpose of this paper is twofold: from one side we provide a general survey to the viscoelastic models constructed via fractional calculus and from the other side we intend to analyze the basic fractional models as far as their creep, relaxation and viscosity properties are considered. The basic models are those that generalize via derivatives of fractional order the classical mechanical models characterized by two, three and four parameters, that we refer to as Kelvin-Voigt, Maxwell, Zener, anti-Zener and Burgers. For each fractional model we provide plots of the creep compliance, relaxation modulus and effective viscosity in non dimensional form in terms of a suitable time scale for different values of the order of fractional derivative. We also discuss the role of the order of fractional derivative in modifying the properties of the classical models.Comment: 41 pages, 8 figure

Real-Time Telemetry Options for Ocean Observing Systems

Ocean observing systems provide a means to monitor oceanic variables on a variety of temporal and spatial scales. Data from ocean observing systems are most useful when they are collected in real-time; real-time data allow the detection of important events as they occur. Various real-time telemetry options exist for transferring data from sea to shore and from the subsurface to the surface. We survey these telemetry options to highlight the research problems associated with subsea to surface to shore networking and include a comparison of existing real-time technologies for three specific ocean observing system network topologies with respect to data transmission rates, power requirements, and cost. We conclude that cellular technology may prove to be the best means for sea to shore transmission in nearshore regions whereas Iridium satellite communications are ideal for locations not covered by cellular service. Further advances in cabled mooring lines and inductive and acoustic modem technologies will make these more attractive options for subsurface to surface data transmissions

hMENA11a contributes to HER3-mediated resistance to PI3K inhibitors in HER2-overexpressing breast cancer cells.

Human Mena (hMENA), an actin regulatory protein of the ENA/VASP family, cooperates with ErbB receptor family signaling in breast cancer. It is overexpressed in high-risk preneoplastic lesions and in primary breast tumors where it correlates with HER2 overexpression and an activated status of AKT and MAPK. The concomitant overexpression of hMENA and HER2 in breast cancer patients is indicative of a worse prognosis. hMENA is expressed along with alternatively expressed isoforms, hMENA11a and hMENAΔv6 with opposite functions. A novel role for the epithelial-associated hMENA11a isoform in sustaining HER3 activation and pro-survival pathways in HER2-overexpressing breast cancer cells has been identified by reverse phase protein array and validated in vivo in a series of breast cancer tissues. As HER3 activation is crucial in mechanisms of cell resistance to PI3K inhibitors, we explored whether hMENA11a is involved in these resistance mechanisms. The specific hMENA11a depletion switched off the HER3-related pathway activated by PI3K inhibitors and impaired the nuclear accumulation of HER3 transcription factor FOXO3a induced by PI3K inhibitors, whereas PI3K inhibitors activated hMENA11a phosphorylation and affected its localization. At the functional level, we found that hMENA11a sustains cell proliferation and survival in response to PI3K inhibitor treatment, whereas hMENA11a silencing increases molecules involved in cancer cell apoptosis. As shown in three-dimensional cultures, hMENA11a contributes to resistance to PI3K inhibition because its depletion drastically reduced cell viability upon treatment with PI3K inhibitor BEZ235. Altogether, these results indicate that hMENA11a in HER2-overexpressing breast cancer cells sustains HER3/AKT axis activation and contributes to HER3-mediated resistance mechanisms to PI3K inhibitors. Thus, hMENA11a expression can be proposed as a marker of HER3 activation and resistance to PI3K inhibition therapies, to select patients who may benefit from these combined targeted treatments. hMENA11a activity could represent a new target for antiproliferative therapies in breast cancer

Prevalence of Ca Blood Type and Alloantibodies in a Population of Horses from Italy

A knowledge of the blood groups and alloantibodies present is essential for the safe transfusion of blood products in horses. Pre-transfusion screening and blood typing minimizes the risk of incompatible RBC transfusions and prevents immunization of the recipient against incompatible RBC antigens. The frequencies of blood groups can vary among different breeds. Knowledge of a breed's blood group prevalence can be very useful for identifying the best blood donors during transfusion in clinical practice. The aims of this study were to estimate the prevalence of the Ca blood type in horses from Italy using a monoclonal immunocromatographic method and to estimate the prevalence of anti-Ca alloantibodies in Ca- horses using agglutination on gel technique. Ca blood type was determined on 110 whole blood samples. The prevalence of the Ca+ blood type was 79.1%. This study also provides data about the prevalence of Ca+ blood group in Italian Saddle Horses (77,3%) and Dutch Warmblood (58,3%). No significant association was found between Ca blood type and sex with 79.5% and 78.8% of females and males testing Ca+, respectively. The total number of Ca- samples with detectable anti-Ca alloantibodies was 7/23 (30.4%)

Multiple genome relationships and a complex biogeographic history in the eastern range of Quercus suber L. (Fagaceae) implied by nuclear and chloroplast DNA variation

The complex evolutionary history of Quercus suber has been throughly investigated in many recent works, but the details of its differentiation processes are still largely unknown. In addition, the geographical and evolutionary roles of the eastern parts of the species range have gained much less attention compared to other southern European areas. In order to fill this gap, new insights to infer the species diversification and range establishment of the cork oak in the east-central Mediterranean are here provided by means of inter- and intra-specific plastid DNA and nuclear ribosomal ITS phylogeographic studies. We analyzed 95 natural cork oak populations; 6 closely related, sympatric oaks were included in the study and used for comparisons.Evidence for a clear phylogeographical structure was detected with PCR-RFLP at 5 chloroplast loci, while ITS sequence variation is apparently unrelated with the geographical distribution. Five chloroplast haplotypes and three ITS main lineages were identified. Three haplotypes and all ITS lineages occur in the Italian Peninsula, stressing the importance of these territories for the evolutionary history of the species. Two divergent "Italian" haplotypes are highly shared, and one ITS variant is basal to the ingroup, revealing sister relationships within Cerris taxonomic group. Hypotheses of hybridization, lineage sorting of ancient DNA polymorphisms and of reticulate evolution of the whole species group are presented and discussed

[177Lu]Lu-DOTA-TATE versus standard of care in adult patients with gastro-enteropancreatic neuroendocrine tumours (GEP-NETs): a cost-consequence analysis from an Italian hospital perspective

Purpose: To assess and compare clinical outcomes and costs, to the Italian healthcare system, of three therapeutic options approved in the management of adult patients with gastro-enteropancreatic neuroendocrine tumours (GEP-NETs). Methods: We compared the efficacy, safety, and costs of [177Lu]Lu-DOTA-TATE, everolimus (both originator and generic products), and sunitinib in patients with advanced GEP-NETs (NET G1 and G2) that had progressed following treatment with somatostatin analogs (SSAs). A cost-consequence model was developed and validated by a panel of clinical experts from three NET reference centres in Italy. The clinical outcomes included in the model were median progression-free survival and the incidence of grade 3 or 4 adverse events (AEs), as reported in pivotal clinical trials. The costs for acquisition and administration of each treatment, and of managing AEs, were calculated from the perspective of the Italian national health service. Treatment costs per progression-free month were calculated separately for patients with NETs of pancreatic (PanNETs; all three treatments) and gastrointestinal (GI-NETs; [177Lu]Lu-DOTA-TATE and everolimus only) origin. Results: In patients with PanNETs, total costs per progression-free month were €2989 for [177Lu]Lu-DOTA-TATE, €4975 for originator everolimus, €3472 for generic everolimus, and €5337 for sunitinib. In patients with GI-NETs, total costs per progression-free month were €3189 for [177Lu]Lu-DOTA-TATE, €4990 for originator everolimus, and €3483 for generic everolimus. Conclusions: [177Lu]Lu-DOTA-TATE was associated with lower costs per progression-free month versus relevant treatment options in patients with GI-NETs or PanNETs (NET G1–G2; progressed following SSA treatment), although acquisition and administration costs are higher. These findings provide further economic arguments in the overall context of treatment decision-making

FAbry STabilization indEX (FASTEX) : an innovative tool for the assessment of clinical stabilization in Fabry disease

Two disease severity scoring systems, the Mainz Severity Score Index (MSSI) and Fabry Disease Severity Scoring System (DS3), have been validated for quantifying the disease burden of Fabry disease. We aimed to develop a dynamic mathematical model [the FASTEX (FAbry STabilization indEX)] to assess the clinical stability. A multidisciplinary panel of experts in Fabry disease first defined a novel score of severity [raw score (RS)] based on three domains with a small number items in each domain (nervous system domain: pain, cerebrovascular events; renal domain: proteinuria, glomerular filtration rate; cardiac domain: echocardiography parameters, electrocardiograph parameters and New York Heart Association class) and evaluated the clinical stability over time. The RS was tested in 28 patients (15 males, 13 females) with the classic form of Fabry disease. There was good statistical correlation between the newly established RS and a weighted score (WS), with DS3 and MSSI (R (2) = 0.914, 0.949, 0.910 and 0.938, respectively). In order to refine the RS further, a WS, which was expressed as a percentage value, was calculated. This was based on the relative clinical significance of each item within the domain with the panel agreeing on the attribution of a different weight of clinical damage to a specific organ system. To test the variation of the clinical burden over time, the RS was repeated after 1 year. The panel agreed on a cut-off of a 20% change from baseline as the clinical WS to define clinical stability. The FASTEX model showed good correlation with the clinical assessment and with clinical variation over time in all patients